Skip to main content
Premium Trial:

Request an Annual Quote

PacBio Aims to Raise $60M in Public Offering

NEW YORK (GenomeWeb) – Pacific Biosciences plans to sell more than 14.1 million shares of its common stock at $4.25 per share, the company said today.

The Menlo Park, California-based single-molecule sequencing firm expects gross proceeds of around $60 million from the offering. As reported earlier this week, the firm plans to use the proceeds for capital expenditures, working capital, and other general purposes, and may also use some of the proceeds to acquire or invest in complementary businesses or technologies.

Underwriters will have a 30-day option to purchase up to an additional 2.1 million shares of stock.

The offering is pursuant to a $150 million shelf offering declared effective in August 2017.

In Wednesday morning trading on the Nasdaq, the firm's stock was up 3 percent at $4.72 

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.